成人遗传性球型红细胞增多症诱发重度高胆红素血症1例报告
DOI: 10.3969/j.issn.1001-5256.2023.08.023
伦理学声明:本例报告已获得患者知情同意。
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:阿卜杜萨拉木·图尔荪麦麦提、张云飞负责课题设计,资料分析,撰写论文;阿卜杜萨拉木·图尔荪麦麦提参与收集数据,修改论文;张云飞、姚刚、沙地克·阿帕尔,吐尔洪江·吐逊,温浩负责提出修改意见及定稿。
-
摘要: 遗传性球型红细胞增多症是一种人体红细胞膜缺陷遗传性溶血疾病,主要以贫血、黄疸、脾大为主要症状,因临床症状不典型,容易误诊漏诊,目前临床上总胆红素及直接胆红素极高病例较少见,国内外很少有报道,文本患者入院接受治疗时总胆红素高达1 686.01 μmol/L,直接胆红素高达1 166.6 μmol/L。经外科治疗该患者顺利出院,术后随访一般情况佳,生活质量高,本文总结了外科治疗遗传性球型红细胞增多症的相关诊疗经验。Abstract: Hereditary spherocytosis is a type of hereditary hemolytic disease with human erythrocyte membrane defects and has the main symptoms of anemia, jaundice, and splenomegaly. Since its clinical symptoms are not typical, misdiagnosis or missed diagnosis is often observed. At present, there are rare cases with extremely high levels of total bilirubin and direct bilirubin in clinical practice, with few reports in China and globally. In this study, the patient had a total bilirubin level of 1 686.01 μmol/L and a direct bilirubin level of 1 166.6 μmol/L on admission. The patient was successfully discharged after surgical treatment and had good general conditions and high quality of life during follow-up. This article summarizes the experience in the diagnosis and surgical treatment of hereditary spherocytosis.
-
Key words:
- Polycythemia /
- Hyperbilirubinemia /
- Postoperative Complications
-
-
[1] SHEN Y, LI MY, LIU XN, et al. ERC nursing care of a child with hereditary spherocytosis complicated with cholelithiasis: A case report[J]. Nurs Pract Res, 2021, 18(24): 3783-3786. DOI: 10.3969/j.issn.1672-9676.2021.24.039.沈艳, 李梦圆, 刘细妮, 等. 小儿遗传性球型红细胞增多症合并胆石症行ERC护理1例[J]. 护理实践与研究, 2021, 18(24): 3783-3786. DOI: 10.3969/j.issn.1672-9676.2021.24.039. [2] YANG L, SHI R, ZHANG YM. A case of extremely hyperbilirubinemia caused by hereditary spherocytosis combined with choledocholithiasis[J]. Chin J Hepatobiliary Surg, 2018, 24(12): 806, 811. DOI: 10.3760/cma.j.issn.1007-8118.2018.12.004.杨龙, 史瑞, 张雅敏. 遗传性球形红细胞增多症合并胆总管结石致极高胆红素血症一例[J]. 中华肝胆外科杂志, 2018, 24(12): 806, 811. DOI: 10.3760/cma.j.issn.1007-8118.2018.12.004. [3] LIN YB, SONG CY, LYU Y, et al. Clinical analysis of hereditary spherocytosis[J]. Int J Blood Transfus Hematol, 2020(2): 155-159. https://cdmd.cnki.com.cn/Article/CDMD-10403-1022636616.htm林云碧, 宋春艳, 吕瑜, 等. 遗传性球型红细胞增多症的临床分析[J]. 国际输血及血液学杂志, 2020(2): 155-159. https://cdmd.cnki.com.cn/Article/CDMD-10403-1022636616.htm [4] LIN QS, LI S, JIANG N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biol, 2019, 26: 101254. DOI: 10.1016/j.redox.2019.101254. [5] ZHANG D, WAN WQ. Hereditary polycythemia caused by mutation of ANK1 gene: A case report[J]. J Clin Pediatr, 2017, 35(9): 691-693. DOI: 10.3969/j.issn.1000-3606.2017.09.014.张丹, 万伍卿. ANK1基因突变致遗传性球型红细胞增多症1例报告[J]. 临床儿科杂志, 2017, 35(9): 691-693. DOI: 10.3969/j.issn.1000-3606.2017.09.014. [6] ZHOU D, CHEN YW, CAO HX, et al. Hyperbilirubinemia in a patient with hereditary spherocytosis and intrahepatic cholestasis[J]. J Pract Hepatol, 2015, 18(3): 310-311. DOI: 10.3969/j.issn.1672-5069.2015.02.028.周达, 陈源文, 曹海霞, 等. 遗传性球形红细胞增多症合并肝内胆汁淤积致严重高胆红血症1例[J]. 实用肝脏病杂志, 2015, 18(3): 310-311. DOI: 10.3969/j.issn.1672-5069.2015.02.028. [7] WEI NX, DING F, WANG SM, et al. Hereditary spherocytosis combined with malignant obstructive jaundice caused extreme hyperbiliru-binemia: A case report[J]. Chin J Hepatobiliary Surg, 2019, 25(10): 782-783. DOI: 10.3760/cma.j.issn.1007-8118.2019.10.017.魏宁心, 丁飞, 王石鸣, 等. 遗传性球形红细胞增多症合并恶性梗阻性黄疸致超高胆红素血症一例[J]. 中华肝胆外科杂志, 2019, 25(10): 782-783. DOI: 10.3760/cma.j.issn.1007-8118.2019.10.017. [8] TRIPODI SI, SHAMBERGER RC, HEENEY MM, et al. Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis[J]. Pediatr Hematol Oncol, 2019, 36(6): 382-389. DOI: 10.1080/08880018.2019.1637983. [9] WU ZQ. Acute renal failure[J]. Chin Pract J Rural Dr, 2022, 29(7): 14-15. DOI: 10.3969/j.issn.1672-7185.2022.07.007.吴钟琪. 急性肾衰竭[J]. 中国实用乡村医生杂志, 2022, 29(7): 14-15. DOI: 10.3969/j.issn.1672-7185.2022.07.007. [10] YE P, CHENG F. Role and mechanism of mitochondria in renal ischemia-reperfusion injury[J]. Med Recapitul, 2022, 28(4): 643-648. DOI: 10.3969/j.issn.1006-2084.2022.04.004.叶芃, 程帆. 线粒体在肾脏缺血再灌注损伤中的作用与机制[J]. 医学综述, 2022, 28(4): 643-648. DOI: 10.3969/j.issn.1006-2084.2022.04.004.